Skip to main content
. 2016 Aug 30;16(1):161. doi: 10.1186/s12872-016-0343-y

Table 3.

Baseline features of the studies included

Studies Mean age Males (%) HT (%) Ds (%) Cs (%)
S/L S/L S/L S/L S/L
Brar2008 62.9/62.9 70.0/70.0 - - -
I-LOVE IT 2 60.4/60.0 67.2/68.7 61.0/64.8 25.3/23.4 24.2/24.9
ISAR-SAFE 67.2/67.2 80.7/80.5 90.1/91.5 87.5/87.4 24.9/25.7
Tarantini2016 65.5/66.7 71.8/74.0 82.5/80.3 69.4/70.9 18.9/20.2
ARCTIC 64.0/64.0 81.0/80.0 62.0/59.0 68.0/67.0 24.0/23.0
OPTIMIZE 61.3/61.9 63.5/63.1 86.4/88.2 63.2/63.7 18.6/17.3
RESET 62.4/62.4 64.4/62.9 62.3/61.4 57.7/59.9 25.2/22.8
EXCELLENT 63.0/62.4 65.1/63.9 72.7/73.8 75.2/76.3 27.4/25.8
PEGASUS 65.0/66.0 77.0/77.0 76.0/76.0 76.0/77.0 16.0/17.0
DAPT 61.6/61.8 74.0/75.3 74.0/75.8 - 24.7/24.6
Sardella2011 61.9/61.2 78.2/81.3 76.7/74.8 57.1/64.0 48.1/62.6
PRODIGY 70.0/68.0 75.0/78.0 71.0/72.0 62.0/66.0 12.0/15.0
Thukkani2015 64.3/64.3 98.5/98.5 97.1/97.8 - 34.8/33.3
ENDEAVOR 62.4/63.6 69.6/69.4 73.6/79.5 80.5/81.4 52.3/56.2
ITALIC 61.7/61.5 80.8/79.2 65.2/64.7 67.1/67.1 50.9/52.7

Abbreviations: S short term DAPT use, L prolonged DAPT use, HT hypertension, Ds dyslipidemia, Cs current smoking